Tips for Contact Dermatitis Patients with Dr. David E. Cohen
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. David E. Cohen (Charles C. and Dorothea E. Harris Professor of Dermatology, Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine) on patch testing for allergic contact dermatitis in atopic dermatitis pati …
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. David E. Cohen (Charles C. and Dorothea E. Harris Professor of Dermatology, Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine) on patch testing for allergic contact dermatitis in atopic dermatitis pati … Continue reading "Tips for Contact Dermatitis Patients with Dr. David E. Cohen"
Allure recently posted a first-person account of acne excoriée. How can dermatologists best counsel patients who pick their acne lesions, and what tools can help address the urge to pick?
For expert advice, I reached out to dermatologist and clinical psychologist Rick Fried, MD, PhD, clinical director of Yardley Dermatology Associates and Yardley Clinical Research Associates in Yardley, Pa.
… 
A 70-year-old female presents for treatment of a large tumor shown on her face. It has been increasing in size for over 10 years. Which of the following medication is FDA approved for locally advanced basal cell carcinoma that is not amenable to surgical therapy?
A. Ipilimumab
B. Sonidegib
C. Erolitinib
D. Interferon alpha
E. 5-fluorouracil
To find out the correct answer and re … 
Chronic idiopathic urticaria is urticaria for greater than 6 weeks without an identifiable trigger. Cases relapse in 20% of patients for more than 5 years and be difficult to manage; however, omalizumab is a recently approved option for treatment of chronic idiopathic urticaria showing beneficial outcomes.1 Omalizumab is an injectable monoclonal antibody that has been FDA approved not just for chr … 
How to treat acne scars is a popular topic in the consumer press this month. Online articles discussed the benefits and limitations of both chemical peels and scar creams.
What advice is your acne patients reading about fading their acne scars and post-inflammatory hyperpigmentation? Find out by reviewing this list of articles about hot dermatology topics in the consumer press:
Allur … 